The largest database of trusted experimental protocols

8 protocols using lsr 2 cytometer

1

Measuring PD-L1 Expression in A549 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PD‐L1 expression in A549 cells was determined by flow cytometry. A549 cells were pretreated with indole‐3‐carbinol (I3C) (S2313; Selleckchem) and Ruxolitinib (S1378; Selleckchem) for 1 h, following by treating with 10 ng/ml TNF‐α and 10 ng/ml IFN‐γ for 48 h. Cells were dispersed and resuspended in FACS buffer followed by incubation with PD‐L1 antibody (104763; GeneTex) for 1 h. After that, PD‐L1 antibody was captured by donkey anti‐Rabbit IgG‐Alexa Fluor 488 (A21206; Thermo Fisher Scientific). The stained cells were analyzed using an LSR II cytometer, and data were processed using FlowJo V10 software.
+ Open protocol
+ Expand
2

Cell Cycle Analysis with Verapamil and Vybrant Dye

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell cycle analysis, cells were suspended in DPBS + S and treated with 50 μM verapamil (Sigma-Aldrich) for 5 min at 37°C. Subsequently, cells were labeled with 5–10 μM Vybrant DyeCycle Violet Stain (ThermoFisher Scientific) for an additional 30 min at 37°C. Cells were then cooled on ice for 5 min and labeled with antibodies, as noted above, except that all washes and antibody incubations were performed with ice-cold DPBS + S containing 50 μM verapamil and 5 μM Vybrant DyeCycle Violet Stain. Evaluation of cell staining was performed utilizing an LSRII cytometer and cell cycle state was determined from these data using FlowJo v.10.0.7 with the Cell Cycle Univariate analysis [16 (link)]. Results were from four independent labeling experiments.
+ Open protocol
+ Expand
3

Comprehensive Phenotyping of Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All analyses were performed on fresh PBMCs obtained by Ficoll gradient centrifugation. The following antibodies were used for flow cytometric analyses: anti‐CD4 PerCP, anti‐CD25 PE, anti‐FoxP3 Pacific Blue or Alexa Fluor 488 (clone 259D and clone 150D, the latter specifically detecting exon 2), anti‐Helios Pacific Blue, anti‐CD45RA eFluor 780 and anti‐CD39 Brilliant Violet 510 (Ozyme, Biolegend or Thermo Fisher Scientific, eBioscience, VILLEBON‐SUR‐YVETTE, France). Membrane staining was performed in 106 PBMCs. Cells were fixed and permeabilised (Fixation and Permeabilization Buffer; Thermo Fisher Scientific, eBioscience) before intracellular staining. Data were acquired on a BD Biosciences LSRII cytometer and analysed with FlowJo® v10 software.
+ Open protocol
+ Expand
4

Intracellular Cytokine Profiling of Memory CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For intracellular staining of IFN-γ and TNF-α, 6 × 105 memory CD4+ T cells were treated either scr- or Kv1.3-NPs and maintained overnight in T cell medium with 2% human serum as described above (Sections 2.3 and 2.4). Cells were then activated for 3 h with PMA/ionomycin in the presence of BD GolgiPlug Protein Transport Inhibitor (1 μl GolgiPlug/1 ml medium, BD Biosciences Cat#: 555029), fixed in 1% paraformaldehyde (Affymetrix), permeabilized with BD Perm/Wash buffer for 15 min and then stained for intracellular cytokines with APC-anti-IFN-γ (Biolegend, Cat#: 502511) and PerCP-anti-TNF-α (Biolegend, Cat#: 502923). Cells were then centrifuged and resuspended in cell staining buffer (Biolegend) and analyzed by flow cytometry (LSR II cytometer and FlowJo software).
+ Open protocol
+ Expand
5

PBMC Stimulation and Intracellular Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stimulated overnight with pools of 15–amino acid peptides overlapping by 11, spanning the whole RHV polypeptide sequence (1 µg/mL). Dimethyl sulfoxide (DMSO) was applied to negative controls and phorbol 12‐myristate 13‐acetate/ionomycin to positive controls. Mouse antirat cluster of differentiation 28 (CD28; BD Pharmingen, 1:62.5) was added to each well. One million to 3 million PBMCs per well were incubated with peptide pools or controls (2 hours, 37°C) then Golgi Plug (BD Pharmingen; 1:1,000, 16‐18 hours, 37°C). After incubation with mouse antirat CD32 (BD Pharmingen; 1:100, RT, 15 minutes), a surface‐staining cocktail was applied (30 minutes) (Supporting Table S3), followed by fixation and permeabilization (Cytofix/Cytoperm; BD Biosciences), cell washing (Perm/Wash buffer; BD Biosciences), and intracellular staining (30 minutes) (Supporting Table S1). Cells were acquired on an LSR II cytometer, and the results were analyzed using FlowJo software (version 10).
+ Open protocol
+ Expand
6

Quantifying αSMA in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
αSMA was quantified by flow cytometry in cultures, with or without 5 ng/mL of TGFβ, and/or 100 nM of substance P. Cells were trypsinized, fixed in 70% ethanol, and treated with acid, as described for BrdU staining above. 50 µL of anti-αSMA-Alexa 488 (abcam, Burlingame, CA, USA, Catalog # ab202295) at a dilution of 1:500 was added to the cell pellets after neutralization. Data were collected on the LSRII cytometer and analyzed using Flowjo software version 10.10.0.
+ Open protocol
+ Expand
7

T Cell Depletion and HIV Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
HLACs were infected with a X4 virus by spinoculation as explained before. After 3 days, uninfected cells were labeled with CellTrace CFSE (2 µM, Invitrogen) for 5 min at room temperature. Uninfected-CFSE+ (0.6 × 106 cells) were pre-treated for 2 h with or without autophagy inhibitors at 37 °C. Then, infected or uninfected CFSE- cells were added to the treated CFSE+ target cells in a ratio 1:1, incubated in the presence or absence of drugs for 2 days at 37 °C, collected and analyzed by flow cytometry. Cells were stained with the antibodies CD3-APC-Cy7, CD4-APC and CD8-PerCP (BioLegend), fixed and permeabilized (FIX & PERM kit, Thermo Fisher) and stained with anti-p24 antibody (KC57-PE, Coulter). To calculate CD4+ T cell depletion, total live lymphocytes were first gated according to forward and side scatter and then gated on the CD3+ population. Next, CFSE+ cells were selected, CD4+ and CD8+ T cells were gated and CD4+/CD8+ ratio was obtained. Cell depletion was calculated as a percentage compared to the uninfected control as previously described22 (link). To analyze intracellular p24 level, CD3+ CFSE+ cells were gated and CD8-negative cells were selected to include both CD4-positive and CD4-negative cells. Data was acquired in a LSRII cytometer and analyzed with FlowJo software.
+ Open protocol
+ Expand
8

Quantifying ACE2-Spike Protein Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibody interference of spike extracellular domain (ECD) protein with His tag binding to human ACE2 receptor on the cell surface was measured by flow cytometry. HEK-293T cells were seeded at a density of 2.5 × 105 cells per mL in a 15 cm dish. After reaching 70-80% confluency, cells were transformed with lentiviral vectors encoding human ACE2. Cells were treated G418 for two weeks. ECD protein (0.03 μg) was pre-incubated with mAb (50 μL supernatant) for 30 min at room temperature. ECD protein and mAbs mixtures were added into 24 well plates containing 1 × 105 HEK293T-ACE2 cells for 1 h at room temperature and subjected to flow cytometry. Single-cell suspensions in FACS buffer were centrifuged at 400 × g for 10 min. Cells were subsequently incubated with PE-conjugated mouse anti-His Abs (362603, BioLegend) for 30 min on ice. The stained cells were analyzed using an LSR II cytometer, and data were processed using FlowJo V10 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!